2022年美国心脏病学会年会会议纪要:与糖尿病相关的心血管疾病学术进展  

Proceedings of the 2022 Annual Meeting of American College of Cardiology:Progress of diabetes-related cardiovascular diseases

作　　者：马小莉[1] 张芳芳 Ma Xiaoli;Zhang Fangfang(Department of Endocrinology,Qingdao Hospital,University of Health and Rehabilitaion Sciences(Qingdao Municipal Hospital),Qingdao 266071,China;Department of Endocrinology,Fuzhou First Hospital Affiliated to Fujian Medical University,Fuzhou 350009,China)

机构地区：[1]康复大学青岛医院(青岛市市立医院)内分泌科,青岛266071 [2]福建医科大学附属福州市第一医院内分泌科,福州350009

出　　处：《中华内分泌代谢杂志》2023年第3期273-277,共5页Chinese Journal of Endocrinology and Metabolism

摘　　要：第71届美国心脏病学会年会于2022年4月2日至4月4日在美国华盛顿线上线下举行。作为国际心血管病领域最具影响力的学术会议之一,本次会议向全世界传递心血管领域最前沿的研究进展和学术热点。糖尿病是心血管疾病的高危因素,与心力衰竭、动脉粥样硬化性心血管疾病等关系密切。本文就此次会议中与糖尿病相关的心血管疾病领域学术进展进行总结,旨在为患者的临床管理提供前沿资讯。The 71st Annual Meeting of American College of Cardiology(ACC)was held online and onsite from April 2 to April 4,2022 in Washington,D.C.As one of the most influential academic annual meeting in the field of cardiovascular diseases,the ACC annual meeting delivers the most advanced research progress and academic hotspots in the field of cardiovascular diseases to the world.As diabetes is a high risk factor for cardiovascular disease and is closely related to heart failure,atherosclerotic cardiovascular disease and so on,this article summarizes the academic advances in the field of diabetes-related cardiovascular disease at the conference,with the aim of providing cutting-edge information for the clinical management of patients.

关 键 词：糖尿病 心血管疾病 管理 美国心脏病学会 

分 类 号：R-2[医药卫生]